Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Innovative and ultra-low power neuromorphic unit for advanced signal processing in wearable medical devices

Descripción del proyecto

Unos nuevos dispositivos neuromórficos controlan problemas de salud crónicos en tiempo real

La atención sanitaria en Europa es cada vez más personalizada, gracias al control de la propia salud, y esto es necesario, dado que más de cincuenta millones de personas padecen enfermedades crónicas. Los dispositivos vestibles actuales con un sistema de autocontrol emplean microprocesadores específicos que consumen mucha energía y producen enormes cantidades de datos brutos que deben ser sometidos a complejos análisis posteriores. El proyecto DynapIP tiene como objetivo resolver este problema empleando un chip neuromórfico con requerimientos energéticos sumamente bajos y una batería con una vida útil extremadamente larga. El chip, que produce señales avanzadas en tiempo real como las del sistema neuronal biológico, puede personalizarse con una amplia selección de biosensores (ECG, EOG, EMG y EEG) y revolucionará el diagnóstico porque hace que sea inmediato y fácil.

Objetivo

Nowadays, ~220M of the worldwide population of which over 50M only in EU, currently live with more than one chronic condition. Early and accurate detection of adverse events are fundamental for proper clinical management. To meet this need, the healthcare system is becoming increasingly personalized with the help of self-health monitoring systems and in particular medical wearable devices. However, constant monitoring generates large amounts of raw data which must be stored and processed to extract pathological biomarkers. Normally, this is done using microprocessors commonly found in computers as central processing units (CPUs) or graphic processing units (GPUs), or on specialized microprocessors such as digital signal processors (DSPs) that have some limitations as implying high power consumption (>100W) and no real time signal processing.
aiCTX offers DynapIP, a neuromorphic chip with extremely long battery life (3 months) and low-power consumption (<100uW) able to perform sophisticated signal processing and react to sensory input in real-time enabling continuous monitoring and real time analysis of biological signals captured by wearable medical devices. The hardware can be fully customized based on client needs and these approaches can be applied to a wide variety of biosensors, such as ECG, EOG, EMG and EEG. Wearable devices using DynapIP automatically identify in real-time (less than 100ms) pathological events with high accuracy facilitating faster and immediate diagnosis for healthcare personnel.
During the feasibility assessment, a go-to-market strategy will be established, as well as further development plan will be drafted. During the innovation project, aiCTX will optimize the existing neuron/synapses hardware modules for different biosensors and the software integration to support the new hardware modules of the DynapIP. Pilot study for validation of biosignal analysis and functionality of the technology will be conducted together with secured partners

Programa(s)

Tema(s)

Régimen de financiación

SME-1 - SME instrument phase 1

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-EIC-SMEInst-2018-2020

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

SYNSENSE AG
Aportación neta de la UEn
€ 50 000,00
Dirección
THURGAUERSTRASSE 60
8050 ZURICH
Suiza
Pyme
Sí
Región
Schweiz/Suisse/Svizzera Zürich Zürich
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00